Monographie - Alprostadil

Última actualização :
08/05/2024

Alprostadil

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Alfaprostin	Egipto
Alistint	Peru
Alpros	Turquia
Alprostadil	Alemanha, Argentina, Canadá, Chilli, Equator, Espanha, Estados Unidos de América, Malásia, Peru, Romènia, Turquia
Alprostapint	Argentina, Austria, Colômbia, Equator, Hungria, Peru
Alprostar	Itália
Aplicav	Brasil
Cardiobon	Argentina, Peru
Caverject	Africa do sul, Austria, Bélgica, Brasil, Canadá, Dinamarca, Eslovenia, Espanha, Estados Unidos de América, França, Gran-bretanha, Itália, Noruega, Polonia, Portugal, Suècia, Suicia, Turquia
Edex	França
Liple	Japón
Minprog	Alemanha, Austria
Ostapint	México, Peru
Palux	Japón
Pridax	Alemanha, Austria, Espanha, Romènia
Prolisina VR	Argentina
Prostandin	Japón
Prostavasin	Alemanha, Austria, Egipto, Hungria, Irã, Itália, Luxemburgo, Polonia
Prostin VR	Arábia Saudita, Australia, Bélgica, Canadá, Dinamarca, Estados Unidos de América, Finlandia, Gran-bretanha, Grècia, Hungria, Irã, Itália, Luxemburgo, Malásia, Noruega, Países Baixos, Polonia, Portugal, Suicia, Venezuela
Prostine VR	França
Vasaprostan	Romènia

Bibliografía : Alprostadil

	Tipo	Publicação
1072	Jornal	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899	Jornal	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003	Jornal	Paul M, Razzouq N, Tixier G, Astier A. Stability of prostaglandin E1 (PGE1) in aqueous solutions. EJHP Science 2005 ; 2: 31-36.
2090	Jornal	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2150	Jornal	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
2151	Jornal	Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int J Pharm 1995 ; 115: 113-117.
3201	Jornal	Dice JE. Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448	Jornal	Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761	Livro	Chavan E. Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Master en pharmacie - University of Geneva 2014
3961	Jornal	McCluskey S.V,Kirkham K,Munson J.M. Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069	Jornal	Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. EJHP 2018 ; 25, e2
4389	Jornal	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4491	Jornal	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2020
4507	Jornal	Ross E, Salinas A, Petty K, Her C, Carpenter J. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543	Jornal	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4570	Jornal	Greenhill K, Hornsby E, Gorman G. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 2019
4651	Jornal	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2021 ;180,1169–1176.

Mentions Légales